Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET	Disease Attributes, Disease Progression, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 2	2026-06-04		NCT04954820

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut du Cancer de Montpellier - Val d'Aurelle	67

28 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Antoine Lacassagne	Nice	France	83
Centre François Baclesse	Caen	France	40
Centre Henri Becquerel	Rouen	France	10
Centre Jean Perrin	Clermont-Ferrand	France	58
Centre Léon Bérard	Lyon	France	50
CH Métropole de Savoie	Chambéry	France	1
CHRU Lille	Lille	France	10
CHRU Morvan	Brest	France	3
CHRU Nancy Brabois	Vandœuvre-lès-Nancy	France	8
CHU de Dijon	Dijon	France	19
CHU de Rouen	Rouen	France	27
CHU Grenoble Alpes (CHUGA)	La Tronche	France	1
Chu Nantes	Nantes	France	45
CHU ST Etienne	Saint-Etienne	France	2
Hopital Beaujon	Clichy	France	5
Hospices civils de LYON - GHE	Bron	France	1
Hôpital Cochin	Paris	France	56
Hôpital de La Timone	Marseille	France	13
Hôpital Haut-Lévêque	Pessac	France	6
Hôpital Pitié Salpétrière	Paris	France	3
Hôpitaux Universitaires de Strasbourg	Strasbourg	France	16
ICM Val d'Aurelle	Montpellier	France	19
Institut Bergonié	Bordeaux	France	14
Institut de Cancérologie de l'Ouest	Saint-Herblain	France	29
Institut de Cancérologie de l'Ouest Site d'Angers	Angers	France	1

Clinical trials